Robert M. Wenham
- Molecular Biology top 5%
- Reproductive Medicine top 0.5%
- Cancer Research top 1%
- Oncology top 2%
- Obstetrics and Gynecology top 1%
- Co-authors
- Jin Q. ChengDomenico CoppolaNisha BansalPatricia A. KrukJiawang WangSanto V. NicosiaLili HeWilliam Kong
- Topics
- Ovarian cancer diagnosis and treatment (85 papers)Endometrial and Cervical Cancer Treatments (35 papers)PARP inhibition in cancer therapy (25 papers)
- Journals
- Journal of Biological ChemistryJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Robert M. Wenham
149 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Molecular Biology 2.3k
- Reproductive Medicine 1.4k
- Cancer Research 1.4k
- Oncology 1.4k
- Obstetrics and Gynecology 632
Countries citing papers authored by Robert M. Wenham
This map shows the geographic impact of Robert M. Wenham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Wenham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Wenham more than expected).
Fields of papers citing papers by Robert M. Wenham
This network shows the impact of papers produced by Robert M. Wenham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Wenham. The network helps show where Robert M. Wenham may publish in the future.
Co-authorship network of co-authors of Robert M. Wenham
This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Wenham. A scholar is included among the top collaborators of Robert M. Wenham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Wenham. Robert M. Wenham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 0 | |
| 7 | 23 | |
| 8 | 36 | |
| 9 | 6 | |
| 10 | 3 | |
| 11 | 89 | |
| 12 | 9 | |
| 13 | 1 | |
| 14 | 7 | |
| 15 | 1 | |
| 16 | 13 | |
| 17 | 50 | |
| 18 | A PHASE 1B STUDY OF TREBANANIB (AMG 386) IN COMBINATION WITH PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) OR TOPOTECAN (T) IN WOMEN WITH RECURRENT OVARIAN CANCER | 1 |
| 19 | 7 | |
| 20 | 65 |
About Robert M. Wenham
Robert M. Wenham is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 158 papers that have together received 4.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (85 papers), Endometrial and Cervical Cancer Treatments (35 papers) and PARP inhibition in cancer therapy (25 papers). The work is most often cited by research in Reproductive Medicine (1.4k citations), Cancer Research (1.4k citations) and Obstetrics and Gynecology (632 citations). Robert M. Wenham has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jin Q. Cheng, Domenico Coppola, Nisha Bansal, Patricia A. Kruk, Jiawang Wang, Santo V. Nicosia, Lili He, William Kong, Hua Yang and Jianjun Zhao. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.